삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

방사선종양학과 박희철 교수

진료분야
간암, 대장암, 췌담도암, 특수방사선치료
진료일정 02 月
날짜
토
01
일
02
월
03
화
04
수
05
목
06
금
07
토
08
일
09
월
10
화
11
수
12
목
13
금
14
토
15
일
16
월
17
화
18
수
19
목
20
금
21
토
22
일
23
월
24
화
25
수
26
목
27
금
28
토
29
오전
오후
진료일정 03 月
날짜
일
01
월
02
화
03
수
04
목
05
금
06
토
07
일
08
월
09
화
10
수
11
목
12
금
13
토
14
일
15
월
16
화
17
수
18
목
19
금
20
토
21
일
22
월
23
화
24
수
25
목
26
금
27
토
28
일
29
월
30
화
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2004.08 연세대학교 대학원 졸업 (의학박사)
2001.02 연세대학교 대학원 졸업 (의학석사)
1992.02 연세대학교 의과대학교 졸업 (의학사)

경력

경력
2019.04 ~현재 삼성서울병원 암병원 운영지원실 실장
2019.04 ~현재 삼성서울병원 양성자치료센터장
2016.04 ~현재 삼성서울병원 방사선종양학과 교수
2017.04 ~ 2019.03 삼성서울병원 암병원 운영지원실 실차장
2010.03 ~ 2016.03 삼성서울병원 방사선종양학과 부교수
2007.03 ~ 2010.02 삼성서울병원 방사선종양학과 임상부교수
2006.09 ~ 2007.12 미국 MD Anderson Cancer Center 방문 과학자
2005.11 ~ 2007.02 삼성서울병원 방사선종양학과 임상조교수
2006.07 ~ 2006.08 일본 북해도대학병원 방사선과 방문교수
2004.03 ~ 2005.10 한림대학교성심병원 방사선종양학과 조교수
2002.03 ~ 2004.02 한림대학교성심병원 방사선종양학과 전임강사
2001.11 ~ 2002.02 한림대학교성심병원 방사선종양학과 연구전임강사
2001.03 ~ 2001.10 연세암센타 방사선종양학과 연구강사
2000.03 ~ 2001.02 조선대학교병원 치료방사선과 임상전임의
1996.05 ~ 2000.02 연세암센타 방사선종양학과 전공의
1993.05 ~ 1996.04 전라북도 김제시 보건소 공중보건의사
1992.03 ~ 1993.02 세브란스병원 수련의

연구분야

연구분야
간암의 비수술적 국소치료 (간암의 방사선수술/간암의 양성자치료)
수술, 고주파열치료 등 표준치료가 어려운 간암의 근치적 치료를 위하여 정위절제방사선치료 및 양성자치료를 활용하는 기술 개발 방사선종양학 임상, 방사선 의학 물리 및 방사선 생물학 분야의 융합 연구를 통하여 표준 치료가 어려운 간암의 근치적 양성자 방사선수술 적용 확대 양성자치료 및 병합 요법을 이용한 종양추적 방사선주술 기술 개발 동통, 상처 등이 없는 비관혈적 접근을 통한 환자의 삶의 질 향상

학회활동

학회활동
2016.04 ~ 현재 대한방사선종양학회 연구위원회 직장암분과장
2012.01 ~ 현재 한국임상암학회 기획위원회 위원
2016.07 ~ 2018.06 한국보건의료연구원 연구기획자문단원
2016.01 ~ 2017.12 방사선의학포럼 운영위원
2015.10 ~ 2017.09 대한방사선종양학회 학술위원회 학술이사
2016.07 ~ 2017.06 대한간암학회 재무이사
2011.10 ~ 2015.09 대한방사선종양학회 보험위원회 위원
2011.10 ~ 2015.09 대한방사선종양학회 고시위원회 위원
2014.12 ~ 2014.12 대한방사선종양학회 전문의 고시 선택위원
2011.10 ~ 2013.09 대한방사선종양학회 윤리위원회 위원
2011.10 ~ 2013.09 대한방사선종양학회 국제협력위원회 위원
2011.10 ~ 2013.09 대한방사선종양학회 연구위원회 위원
2012.12 ~ 2012.12 대한방사선종양학회 전문의 고시 선택위원
2009.07 ~ 2012.06 대한간암학회 정보위원장
2010.01 ~ 2011.12 한국임상암학회 학술위원회 위원
2005.02 ~ 2006.12 대한방사선종양학회 QA위원회 간사

수상이력

수상이력
2016.06 제8회 대한암학회 로슈 암학술상
2016.05 대한방사선종양학회 우수심사위원상
  • " alt="" />
  • " alt="" />

방사선치료, 편견과 오해를 벗고 암 치료의 중심에 서다. 암환자들과의 든든한 동행. 방사선종양학과 박희철 교수

Oh Happy SMC 블로그
논문
  • Liver Transpl. 2017 Apr;23(4):545-551. doi: 10.1002/lt.24729. The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus Choi JY11, Yu JI2, Park HC2, David Kwon CH3, Kim JM3, Joh JW3, Choi GS3, Park JB3, Kim SJ3, Lee SH4, Cho WT5, Lee KW3, Na BG3, Oh DK3, Lee N3, Cho CW3, Lee S3, Lee SK3.
    View PubMed
  • Jpn J Clin Oncol. 2017 Apr 1;47(4):328-333. doi: 10.1093/jjco/hyw205. Predictive factors of gastroduodenal bleeding after postoperative radiotherapy in biliary tract cancer Lee J11, Lim DH1, Park HC1, Yu JI1, Choi DW2, Choi SH2, Heo JS2.
    View PubMed
  • Surg Oncol. 2017 Mar;26(1):96-104. doi: 10.1016/j.suronc.2017.01.005. Epub 2017 Feb 2. Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis Wilson MJ11, van Haaren M2, Harlaar JJ3, Park HC4, Bonjer HJ5, Jeekel J6, Zwaginga JJ7, Schipperus M8.
    View PubMed
  • Liver Int. 2017 Feb;37(2):308-309. doi: 10.1111/liv.13278. Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT? Im JH11, Yoon SM2, Park HC3,4, Kim JH2, Yu JI3,4, Kim TH5, Kim JW6, Nam TK7, Kim K8, Jang HS9, Kim JH10, Kim MS11, Yoon WS12, Jung I13, Seong J1.
    View PubMed
  • J Radiat Res. 2017 Jan;58(1):155-163. doi: 10.1093/jrr/rrw089. Epub 2016 Sep 26. Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study Yu JI11, Park HC2,3, Ahn YC1,3, Gao XS4, Wang JJ5, Zeng ZC6, Ito Y7, Ohno T8, Nishimura Y9.
    View PubMed
  • Cancer Res Treat. 2017 Jan;49(1):61-69. doi: 10.4143/crt.2016.097. Epub 2016 Jun 13. Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07) Cha H11,2, Park HC2,3, Yu JI2, Kim TH4, Nam TK5, Yoon SM6, Yoon WS7, Kim JW8, Kim MS9, Jang HS10, Choi Y11, Kim JH12, Kay CS13, Jung I14, Seong J1.
    View PubMed
  • Liver Int. 2017 Jan;37(1):90-100. doi: 10.1111/liv.13191. Epub 2016 Jul 12. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area Im JH11, Yoon SM2, Park HC3,4, Kim JH2, Yu JI3,4, Kim TH5, Kim JW6, Nam TK7, Kim K8, Jang HS9, Kim JH10, Kim MS11, Yoon WS12, Jung I13, Seong J1.
    View PubMed
  • Sci Rep. 2017 Jan 19;7:40922. doi: 10.1038/srep40922. Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation Oh D11, Hong CS1, Ju SG1, Kim M1, Koo BY1, Choi S1, Park HC1, Choi DH1, Pyo H1.
    View PubMed
  • STRAHLENTHERAPIE UND ONKOLOGIE, OCT 2016, 192(10):714-721, DOI: 10.1007/s00066-016-1028-2 Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma Kim YS1, Kim JW, Yoon WS, Kang MK, Lee IJ, Kim TH, Kim JH, Lee HS, Park HC, Jang HS
    View PubMed
  • Support Care Cancer. 2016 Oct;24(10):4399-406. doi: 10.1007/s00520-016-3280-5. Epub 2016 May 24. Evaluation of quality of life using a tablet PC-based survey in cancer patients treated with radiotherapy: a multi-institutional prospective randomized crossover comparison of paper and tablet PC-based questionnaires (KROG 12-01) Kim H11, Park HC2,3, Yoon SM4, Kim TH5, Kim J6, Kang MK7, Jung J8, Kim SW7, Yea JW7, Park SH9, Park YS10.
    View PubMed
  • Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
    View PubMed
  • World J Gastroenterol. 2016 Aug 14;22(30):6851-63. doi: 10.3748/wjg.v22.i30.6851. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis Yu JI11, Park HC1.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):1102-9. doi: 10.4143/crt.2015.207. Epub 2015 Dec 2. Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014 Yu JI11, Park HC1,2, Ahn YC1,2, Chung Y1, Koom WS3, Song SY4.
    View PubMed
  • Medicine (Baltimore). 2016 Jul;95(28):e4123. doi: 10.1097/MD.0000000000004123. Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma Yu JI11, Lim do H, Park HC, Nam H, Kim BK, Kim SJ, Park JB.
    View PubMed
  • J Cancer Res Clin Oncol. 2016 Jun;142(6):1377-85. doi: 10.1007/s00432-016-2148-x. Epub 2016 Mar 24. Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer Oh BY11, Park YA1, Huh JW1, Cho YB1, Yun SH1, Lee WY1, Park HC2, Choi DH2, Park YS3, Kim HC4.
    View PubMed
  • Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
    View PubMed
  • Cancer Res Treat. 2016 Apr;48(2):574-82. doi: 10.4143/crt.2015.076. Epub 2015 Jul 17. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter? Yu JI11, Park HC1, Lim DH1, Paik SW2.
    View PubMed
  • Gut Liver. 2016 Mar;10(2):164-5. doi: 10.5009/gnl16014. Is the Use of Intensity-Modulated Radiotherapy Beneficial for Pancreatic Cancer Patients 1,Park HC1.
    View PubMed
  • PLoS One. 2016 Mar 29;11(3):e0152642. doi: 10.1371/journal.pone.0152642. eCollection 2016. Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: AMulti-Institutional Retrospective Study (KROG 13-05) Jung J11, Yoon SM2, Park HC3,4, Nam TK5, Seong J6, Chie EK7, Kim TH8, Kim MS9, Kim CY10, Jang HS11, Kim JH2.
    View PubMed
  • Radiother Oncol. 2016 Feb;118(2):408-15. doi: 10.1016/j.radonc.2015.11.019. Epub 2016 Jan 28. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study Yu JI11, Park JW2, Park HC3, Yoon SM4, Lim do H1, Lee JH5, Lee HC6, Kim SW7, Kim JH2.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2582. doi: 10.1097/MD.0000000000002582. Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation Huh JW11, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Park HC, Choi DH, Park JO, Park YS, Chun HK.
    View PubMed
  • Tumori. 2016 Jan-Feb;102(1):114-21. doi: 10.5301/tj.5000439. Epub 2015 Oct 7. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery Kim TG11, Park W2, Choi DH2, Park HC2, Kim SH3, Cho YB4, Yun SH4, Kim HC4, Lee WY4, Lee J5, Park JO5, Park YS5, Lim HY5, Kang WK5, Chun HK6.
    View PubMed
  • Med Phys. 2015 Oct;42(10):6021-7. doi: 10.1118/1.4931411. A virtual simulator designed for collision prevention in proton therapy Jung H11, Kum O2, Han Y3, Park HC3, Kim JS3, Choi DH3.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):727-37. doi: 10.4143/crt.2014.018. Epub 2014 Dec 2. Dosimetric and Clinical Influence of 3D Versus 2D Planning in Postoperative Radiation Therapy for Gastric Cancer Lee JA11, Ahn YC2, Lim do H2, Park HC2, Asranbaeva MS3.
    View PubMed
  • World J Surg Oncol. 2015 Jul 29;13:227. doi: 10.1186/s12957-015-0637-z. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study Gil E11, Joh JW2, Park HC3, Yu JI4, Jung SH4, Kim JM5.
    View PubMed
  • Oncology. 2015;89(1):14-22. doi: 10.1159/000371390. Epub 2015 Mar 11. Is Chemoradiotherapy Beneficial for Stage IV Rectal Cancer Huh JW11, Kim HC, Park HC, Choi DH, Park JO, Park YS, Park YA, Cho YB, Yun SH, Lee WY, Chun HK.
    View PubMed
  • Med Phys. 2015 May;42(5):2626-37. doi: 10.1118/1.4916663. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy Ahn SH11, Gil MS2, Lee DS2, Han Y3, Park HC3, Sohn JW4, Kim HY5, Shin EH5, Yu JI3, Noh JM3, Cho JS3, Ahn SH3, Choi DH3.
    View PubMed
  • Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465. Epub 2015 May 13. 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma Korean Liver Cancer Study Group (KLCSG); National Cancer Center1, Korea (NCC).
    View PubMed
  • Cancer Res Treat. 2015 Apr;47(2):251-8. doi: 10.4143/crt.2014.011. Epub 2014 Oct 27. Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy Oh D11, Shin SW2, Park HC1, Cho SK2, Lim do H1, Paik SW3.
    View PubMed
  • Ann Surg Oncol. 2015 Apr;22(4):1308-14. doi: 10.1245/s10434-014-4146-z. Epub 2014 Oct 16. Salvage Radiation Therapy for Isolated Local Recurrence of Extrahepatic Cholangiocarcinoma After Radical Surgery: A Retrospective Study Kim SW11, Lim do H, Park HC, Park W, Park JO, Park YS.
    View PubMed
  • J Surg Oncol.?2015 Mar 15;111(4):439-44. doi: 10.1002/jso.23835. Epub 2014 Dec 9. Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Curative Resection for Rectal Cancer: Is it Necessary for all Patients Jung KU11,?Kim HC,?Park JO,?Park YS,?Park HC,?Choi DH,?Cho YB,?Yun SH,?Lee WY,?Chun HK.
    View PubMed
  • Yonsei Med J. 2015 Jan;56(1):82-8. doi: 10.3349/ymj.2015.56.1.82. Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis Huh JW11, Lee WY2, Kim SH3, Park YA1, Cho YB1, Yun SH1, Kim HC1, Park HC4, Choi DH4, Park JO5, Park YS5, Chun HK6.
    View PubMed
  • Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270. Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications Yu JI1, Cho JY, Park HC, Lim do H, Gwak GY, Paik SW.
    View PubMed
  • Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial Hong YS11, Nam BH2, Kim KP1, Kim JE1, Park SJ1, Park YS3, Park JO3, Kim SY4, Kim TY5, Kim JH6, Ahn JB7, Lim SB8, Yu CS8, Kim JC8, Yun SH9, Kim JH10, Park JH10, Park HC11, Jung KH1, Kim TW12.
    View PubMed
  • Radiother Oncol. 2014 Oct;113(1):18-23. doi: 10.1016/j.radonc.2014.08.016. Epub 2014 Sep 19. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: Pooled analysis of KROG 10-01 and 11-02 Lee JH11, Jang HS2, Kim JG3, Lee MA4, Kim DY5, Kim TH5, Oh JH5, Park SC5, Kim SY5, Baek JY5, Park HC6, Kim HC7, Nam TK8, Chie EK9, Jung JH10, Oh ST11.
    View PubMed
  • Cancer Res Treat. 2014 Oct;46(4):348-57. doi: 10.4143/crt.2013.142. Epub 2014 Jul 16. Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma Yu JI11, Yoon SM2, Park HC1, Kim JH2, Kim TH3, Park JW3, Seong J4, Lee IJ4, Jang HS5, Kay CS6, Kim CY7, Chie EK8, Kim JH9, Kim MS10, Choi YM11.
    View PubMed
  • Dig Dis. 2014;32(6):755-63. doi: 10.1159/000368018. Epub 2014 Oct 29. Considerations for Radiation Therapy in Hepatocellular Carcinoma: The Radiation Oncologists' Perspective Yu JI11, Park HC.
    View PubMed
  • Cancer Res Treat. 2014 Jul;46(3):243-9. doi: 10.4143/crt.2014.46.3.243. Epub 2014 Jul 15. Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically 12 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06) Noh JM11, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):814-21. doi: 10.1016/j.ijrobp.2014.03.020. The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation Therapy Yu JI11, Park HC2, Lim do H1, Choi Y1, Jung SH1, Paik SW3, Kim SH4, Jeong WK4, Kim YK4.
    View PubMed
  • Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Med Phys.?2014 Feb;41(2):021712. doi: 10.1118/1.4860155. Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer Hong CS11,?Ju SG1,?Kim M1,?Kim JI2,?Kim JM1,?Suh TS3,?Han Y1,?Ahn YC1,?Choi DH1,?Nam H2,?Park HC1.
    View PubMed
  • Int J Colorectal Dis. 2014 Feb;29(2):193-200. doi: 10.1007/s00384-013-1797-3. Epub 2013 Dec 10. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients Kim TG11, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK.
    View PubMed
  • AJR Am J Roentgenol. 2014 Jan;202(1):92-101. doi: 10.2214/AJR.12.10212. Added Value of Diffusion-Weighted MRI for Evaluating Viable Tumor of Hepatocellular Carcinomas Treated With Radiotherapy in Patients With Chronic Liver Disease Park HJ11, Kim SH, Jang KM, Lim S, Kang TW, Park HC, Choi D.
    View PubMed
  • Radiother Oncol. 2014 Jan;110(1):150-4. doi: 10.1016/j.radonc.2013.11.013. Epub 2014 Jan 7. Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02) Lee JH11, Kim JG2, Oh ST2, Lee MA3, Chun HG3, Kim DY4, Kim TH4, Kim SY4, Baek JY4, Park JW4, Oh JH4, Park HC5, Choi DH5, Park YS6, Kim HC7, Chie EK8, Jang HS9.
    View PubMed
  • Med Dosim. 2013 Winter;38(4):359-65. doi: 10.1016/j.meddos.2013.04.002. Epub 2013 Jun 12. Cumulative dose on fractional delivery of tomotherapy to periodically moving organ: A phantom QA suggestion Shin E11, Han Y, Park HC, Sung Kim J, Hwan Ahn S, Suk Shin J, Gyu Ju S, Ho Choi D, Lee J.
    View PubMed
  • Recent developments in radiotherapy for hepatocellular carcinoma
  • Recent advances in the management of hepatocellular carcinoma
  • Strahlenther Onkol. 2013 Jul;189(7):541-6. doi: 10.1007/s00066-013-0343-0. Epub 2013 May 25. Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma Yoon H11, Oh D, Park HC, Kang SW, Han Y, Lim DH, Paik SW.
    View PubMed
  • Am J Clin Oncol. 2013 Apr;36(2):162-6. doi: 10.1097/COC.0b013e3182438dae. The Efficacy of High-dose 3-Dimensional Conformal Radiation Therapy in Patients With Small Hepatocellular Carcinoma Not Eligible for Other Local Modalities Lim do H11, Lee H, Park HC, Lee JA, Kim SW, Yoo BC, Koh KC, Lee JH, Choi MS, Gwak GY, Paik SW.
    View PubMed
  • Tumori. 2013 Mar-Apr;99(2):164-71. doi: 10.1700/1283.14187. Predictive factors for Child-Pugh score elevation in hepatocellular carcinoma patients treated with conformal radiation therapy: dose-volume histogram analysis Yu JI11, Park HC, Lim do H, Park WY.
    View PubMed
  • Br J Radiol. 2013 Jan;86(1021):20120221. doi: 10.1259/bjr.20120221. Evaluation of anatomical landmark position differences between respiration-gated MRI and four-dimensional CT for radiation therapy in patients with hepatocellular carcinoma Yu JI11, Kim JS, Park HC, Lim DH, Han YY, Lim HC, Paik SW.
    View PubMed
  • Cancer. 2012 Oct 15;118(20):4961-8. doi: 10.1002/cncr.27507. Epub 2012 Mar 13. Can the New American Joint Committee on Cancer Staging System Predict Survival in Rectal Cancer Patients Treated With Curative Surgery Following Preoperative Chemoradiotherapy Moon SH11, Kim DY, Park JW, Oh JH, Chang HJ, Kim SY, Kim TH, Park HC, Choi DH, Chun HK, Kim JH, Park JH, Yu CS.
    View PubMed
  • J Korean Med Sci. 2012 Jul;27(7):736-43. doi: 10.3346/jkms.2012.27.7.736. Epub 2012 Jun 29. Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma Yu JI11, Park HC, Lim do H, Kim CJ, Oh D, Yoo BC, Paik SW, Kho KC, Lee JH.
    View PubMed
  • Med Phys. 2012 May;39(5):2396-404. doi: 10.1118/1.3700734. Development of a video-guided real-time patient motion monitoring system Ju SG11, Huh W, Hong CS, Kim JS, Shin JS, Shin E, Han Y, Ahn YC, Park HC, Choi DH.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e603-7. doi: 10.1016/j.ijrobp.2011.09.053. Epub 2011 Dec 28. Salvage Treatment With Hypofractionated Radiotherapy in Patients With Recurrent Small Hepatocellular Carcinoma Bae SH11, Park HC, Lim do H, Lee JA, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Technol Cancer Res Treat. 2012 Feb;11(1):41-8. Volumetric Response Evaluation After Intensity Modulated Radiotherapy in Patients with Supratentorial Gliomas Cho KH11, Choi JH, Kim JY, Lee SH, Yoo H, Shin KH, Kim TH, Moon SH, Lee SH, Park HC.
    View PubMed
  • Oncology. 2011;81 Suppl 1:134-40. doi: 10.1159/000333276. Epub 2011 Dec 22. Multidisciplinary Management of Nonresectable Hepatocellular Carcinoma Park HC11, Seong J, Tanaka M, Zeng ZC, Lim HY, Guan S, Bae SH, Tak WY.
    View PubMed
  • J Korean Med Sci. 2011 Aug;26(8):1014-22. doi: 10.3346/jkms.2011.26.8.1014. Epub 2011 Jul 27. Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy Yu JI11, Park HC, Lim do H, Park W, Yoo BC, Paik SW, Koh KC, Lee JH.
    View PubMed
  • Radiation Therapy for Colorectal Cancer
  • Yonsei Med J. 2010 Jan;51(1):93-9. doi: 10.3349/ymj.2010.51.1.93. Epub 2009 Dec 29. High Dose Three-Dimensional Conformal Boost Using the Real-Time Tumor Tracking Radiotherapy System in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy Park HC11, Shimizu S, Yonesaka A, Tsuchiya K, Ebina Y, Taguchi H, Katoh N, Kinoshita R, Ishikawa M, Sakuragi N, Shirato H.
    View PubMed
  • J Korean Med Sci. 2009 Apr;24(2):248-55. doi: 10.3346/jkms.2009.24.2.248. Epub 2009 Apr 20. Multi-institutional Comparison of Intensity Modulated Radiation Therapy (IMRT) Planning Strategies and Planning Results for Nasopharyngeal Cancer Park SH11, Park HC, Park SW, Oh do H, Choi Y, Kim JK, Ahn YC, Park W, Suh HS, Lee R, Bae H.
    View PubMed
  • Jpn J Clin Oncol. 2009 Mar;39(3):151-7. doi: 10.1093/jjco/hyn158. Epub 2009 Feb 3. Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors Oh D11, Ahn YC, Park HC, Lim do H, Han Y.
    View PubMed